Lira Regional Referral Hospital is set to host the countrywide launch of a groundbreaking new medication, Lenacapavir, a powerful drug designed to prevent HIV infection. This significant event will take place on Friday, April 17, 2026, placing Lira Hospital at the forefront of this vital public health advancement in Uganda.
Lenacapavir is a revolutionary injection that has demonstrated extraordinary success, proving almost completely effective in preventing HIV in clinical tests. What makes this drug truly transformative is its long-lasting nature: it only needs to be administered twice a year, offering sustained protection with minimal effort. This is a monumental step forward in HIV prevention strategies.
Dr. Andrew Odur, the hospital’s Director, explained that the Ministry of Health, working alongside its partners, specifically chose Lira to kickstart this crucial initiative. Preparations are well underway, including thorough training for hospital staff to ensure they are fully equipped to handle and administer this innovative treatment.
This development is being hailed as a tremendous boost to Uganda’s ongoing efforts to curb HIV infections. The availability of a highly effective, long-acting prevention method like Lenacapavir promises to make a significant difference in safeguarding communities and improving public health across the nation.